This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion

Similar documents
Topics of today lectures: Hemostasis

UNIT VI. Chapter 37: Platelets Hemostasis and Blood Coagulation Presented by Dr. Diksha Yadav. Copyright 2011 by Saunders, an imprint of Elsevier Inc.

Hemostasis. Learning objectives Dr. Mária Dux. Components: blood vessel wall thrombocytes (platelets) plasma proteins

Hemostasis and. Blood Coagulation

Anatomy and Physiology

Physiology of. The Blood hemostasis. By prof. Israa f. jaafar

Chapter 19. Hemostasis

Page 1 of 6 THROMBOCYTES

Primary Exam Physiology lecture 5. Haemostasis

-Hashim ahmed is the one who wrote this sheet. I just edited it according to our record.

Part IV Antithrombotics, Anticoagulants and Fibrinolytics

Hemostasis Haemostasis means prevention of blood loss from blood vessels.

Chapter 19 Blood Lecture Outline

Hemostasis Haemostasis means prevention of blood loss from blood vessels.

Ch. 45 Blood Plasma proteins, Coagulation and Fibrinolysis Student Learning Outcomes: Describe basic components of plasma

Moath Darweesh. Omar Sami. Saleem Khreisha. 1 P a g e

Blood clotting. Subsequent covalent cross-linking of fibrin by a transglutaminase (factor XIII) further stabilizes the thrombus.

Blood coagulation and fibrinolysis. Blood clotting (HAP unit 5 th )

PHM142 Lecture 4: Platelets + Endothelial Cells

Bleeding Disorders. Dr. Mazen Fawzi Done by Saja M. Al-Neaumy Noor A Mohammad Noor A Joseph Joseph

Hemostasis and Thrombosis

WHITE PAPERS PRESENTATION VIDEO DOCUMENTATION EXPERIMENT WO NDCLOT. The WoundClot Principals for Effective Bleeding Control PRESENTATION

Coagulation Disorders. Dr. Muhammad Shamim Assistant Professor, BMU

Chapter 19 Cardiovascular System Blood: Functions. Plasma

Bleeding and Haemostasis. Saman W.Boskani HDD, FIBMS Maxillofacial Surgeon

Chapter 11. Lecture and Animation Outline

PHASES OF HAEMOSTASIS

Blood platelets play important role in coagulation.

Blood Lecture Test Questions Set 2 Summer 2012

WBCs production(leucopoiesis):

Branch of medicine that deals with blood, its formation and disorders is called. Three main functions of cardiovascular system are,, and.

Hemostasis. Clo)ng factors and Coagula4on NORMAL COAGULATION. Overview of blood coagula4on. The Cascade Theory 5/1/12. Clot

Haemostasis & Coagulation disorders Objectives:

What are blood clots?

Chapter 14. Blood. Blood Volume. Blood Composition. Blood

Anticoagulants. Pathological formation of a haemostatic plug Arterial associated with atherosclerosis Venous blood stasis e.g. DVT

Thrombosis. Jeffrey Jhang, M.D.

HEME 10 Bleeding Disorders

BIOH122 Human Biological Science 2

Chapter 19 Blood. Functions of blood:

Introduction to coagulation and laboratory tests

Pathology note 8 BLEEDING DISORDER

Blood. Plasma. The liquid part of blood is called plasma. 1. Pale yellow fluid; forms more than half the blood volume.

Coagulation an Overview Dr.Abdolreza Abdolr Afrasiabi Thal assem a & Heamophili hilia G ene i tic R esearc C en er Shiraz Medical Medic University

Blood. The only fluid tissue in the human body Classified as a connective tissue. Living cells = formed elements Non-living matrix = plasma

Blood ESSENTIALS OF HUMAN ANATOMY & PHYSIOLOGY ELAINE N. MARIEB EIGHTH EDITION

Chapter 1. General introduction

Blood ESSENTIALS OF HUMAN ANATOMY & PHYSIOLOGY ELAINE N. MARIEB EIGHTH EDITION

Physiology of Blood. Dr. Hiwa S. Namiq

Chapter 19: Cardiovascular System: Blood

The Cardiovascular System: Blood

Blood ESSENTIALS OF HUMAN ANATOMY & PHYSIOLOGY ELAINE N. MARIEB EIGHTH EDITION

L iter diagnostico di laboratorio nelle coagulopatie congenite emorragiche

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN

Disseminated Intravascular Coagulation. M.Bahmanpour MD Assistant professor IUMS

Diagnosis of hypercoagulability is by. Molecular markers

Hemostasis and fibrinolysis the hemostatic balance

Hemodynamic Disorders, Thromboembolic Disease, and Shock

Review Article Sri Lanka Dental Journal 2016; 46(01) 05-13

Hemodynamic Disorders, Thrombosis, and Shock. Richard A. McPherson, M.D.

Blood. C h a p t e r. PowerPoint Lecture Slides prepared by Jason LaPres Lone Star College - North Harris

Chapter 3. Haemostatic abnormalities in patients with liver disease

Y. Helen Zhang, MD Andy Nguyen, MD 10/28/2012

Blood ESSENTIALS OF HUMAN ANATOMY & PHYSIOLOGY ELAINE N. MARIEB EIGHTH EDITION

Congenital bleeding disorders

ACQUIRED COAGULATION ABNORMALITIES

G. Types of White Blood Cells

General approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013

10. Which of the following immune cell is unable to phagocytose (a) neutrophils (b) eosinophils (c) macrophages (d) T-cells (e) monocytes

WHICH OF THE FOLLOWING COMPRISE A

Oral Anticoagulant Drugs

Blood. Physical Characteristics and Volume. Components of Blood

BLEEDING DISORDERS Simple complement:

Agenda. Components of blood. Blood is Fluid Connective Tissue. Blood: General functions

Blood = Fluid connective tissue. Formed elements in plasma.

Blood. Biol 105 Lecture 14 Chapter 11

Chapter 1 Introduction

A. Blood is considered connective tissue. RBC. A. Blood volume and composition 1. Volume varies - average adult has 5 liters

Essentials of Anatomy and Physiology, 9e (Marieb) Chapter 10 Blood. Multiple Choice

Leukocytes (White Blood Cells)

Approach To A Bleeding Patient

COAGULATIONS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin)

Outline Anti-coagulant and anti-thrombotic drugs Haemostasis and Thrombosis Year 3 Dentistry

From The Perfusion Technology Section, The Texas Heart Institute, P. 0. Box 20345, Houston, Texas

Hematology. The Study of blood

HEART HEALTH WEEK 2 SUPPLEMENT. A Beginner s Guide to Cardiovascular Disease ATHEROSCLEROSIS. Fatty deposits can narrow and harden the artery

An Introduction to Blood and the Cardiovascular System

Unit 10 - Blood The only fluid tissue in the human body. c) Plasma rises to the top (55% of blood)

4/5/17. Blood. Blood. Outline. Blood: An Overview. Functions of Blood

Investigation of blood clotting mechanism in contact with nanofibers

Hemostasis. Coagulation vs anticoagulation

Approach to bleeding disorders &treatment. by RAJESH.N General medicine post graduate

Step 2. Common Blood Tests, and the Coulter Counter Readout

Hemodynamics. Objectives. Filtration across the endothelium 1/17/2017. K[(P cap - P int )-σ(π cap π int )]

Blood (5600 ml "8%" of B.W.) RBCs (Erythrocytes)

Average adult = 8-10 pints of blood. Functions:

Blood Lecture Outline : Fluid Connective Tissue Part I of the Cardiovascular Unit

4/23/2009. September 15, 2008

Chapter 06 Lecture Outline. See separate PowerPoint slides for all figures and tables preinserted into PowerPoint without notes.

Transcription:

This slide belongs to iron lecture and it is to clarify the iron cycle in the body and the effect of hypoxia on erythropoitein secretion

Topics of today lectures: Hemostasis Meaning of hemostasis Mechanisms of hemostasis - Vascular contraction - Platelets plug - Blood coagulation (clotting) - Structure and functions of platelets - Blood coagulation - Mechanisms - Clotting factors - Prevention of clot formation inside normal blood vessels. - Lysis of blood clots (Fibrinolysis)

Meaning of Hemostasis It means prevention of blood loss from circulatory system. Also it concerns with maintaining of blood in the fluid state in the vascular compartment. Hemostasis consists of series of events responsible for the rapid repair of any break in the vascular endothelium. Abnormality in hemostasis system may result in Hemorrhagic disorder or intravascular clotting (Thrombosis)

Haemostasis The haemostatic response to vascular injury has three elements: 1. Vasoconstriction 2. Platelet aggregation 3. Formation of Clot Platelets Blood vessels Clotting factors

Vasoconstriction after cut in blood vessels First response to damage or cut in blood vessels. It is localized response. It occurs almost immediately after cut. The degree of vascular constriction is directly proportional to severity of damage (i.e the more a vessel is traumatized the greater the degree of spasm). The vasoconstriction may last for many minutes and may continue for hours. It narrows the lumen of the vessel to minimize the loss of blood. The aim of vasoconstriction to reduce or stop blood flow from ruptured vessel.

Vasoconstriction (cont.) Nervous reflexes - initiated by pain or other sensory impulses originate from the damaged area. It starts almost immediately after the cut. Local myogenic spasm due to direct damage to vascular wall. The smooth muscle in the vessel wall contracts and the diameter of the blood vessels decreases. Vascular constriction is also mediated by release of local humoral factors from traumatized tissue. Blood platelets release thromboxane A2 and serotonin which are vasoconstrictors.

Second mechanism of hemostasis is formation of Platelets plug (platelets Aggregation)

Characteristics of Platelets Known also as thrombocytes. Smallest of the circulating formed elements diameter 1 to 4 m. Are anuclear bodies produced in bone marrow from the cytoplasm of Megakaryocytes. Normal concentration of platelets in circulation is 150000-300000/ l. Spontaneous hemorrhaging occurs when platelet count gets below 10 x 10 9 /L (10000/ l) Have a life span of 8-12 days. Old platelets are removed by macrophages (mostly in spleen). 75% of platelets are in circulation and 25% in spleen - no. of platelets in circulation is increased after splenectomy Production is regulated by thrombopoietin

Platelets have many of the functional characteristics of whole cells Contain contractile proteins actin, myosin, thrombosthenin. These proteins enable platelets to contract. Endoplasmic reticulum, Golgi apparatus protein synthesis, calcium storage Mitochondria ATP, ADP formation Enzyme systems for synthesis of prostaglandins

Platelets characteristics (cont.) Platelets produce : Clotting factors like Fibrin Stabilizing Factor (clotting factor no. XIII) and von Willebrand factor. Platelet derived growth factor (PDGF) - causes vascular endothelial cells, smooth muscles and fibroblasts to grow and repair damaged vessel wall and stimulates wound healing. Serotonin Prostaglandines ADP Thromboxane A2

Platelets Plasma Membrane Has Glycoprotein coat that repulses normal endothelium while adhering to injured endothelium and any exposed collagen. Contain receptors for collagen. Is rich in phospholipids that activate many steps of clotting process.

FUNCTIONS OF PLATELETS Serotonin released by platelets contributes to VASOCONSTRICTION observed immediately after a vascular injury. Platelets aggregate to PLUG the vascular injury. Platelets provide phospholipids which accelerate the process of CLOTTING. Contractile proteins of the platelets bring about CLOT RETRACTION. Platelets have a growth factor which stimulates mitosis in vascular wall leading to REPAIR of damaged vessels. Platelets seem to be involved in all stages of HEMOSTASIS - from the initial reaction till the final repair.

Platelets production Megakaryocytes, giant cells in the bone marrow, form platelets by pinching off bits of cytoplasm and extruding them into the circulation Colony stimulating factors regulate the production of Megakaryocytes Thrombopoietin, a circulating protein factor (produced in the Liver and Kidney) facilitates maturation of Megakaryocytes. Provides a feedback control for maintaining a normal platelet count. megakaryocytes Platelets released from megakaryocytes

Role of platelets in hemostasis Platelets contribution in hemostasis consists of many steps. Interact with injured vessel wall (adhesion) Interact with each other (mass of platelets) Produce platelets plug Platelet plug is Fragile Can easily be dislodged from the vessel wall **The platelet plug is reinforced by fibrin fibers (clot).

1. Platelet Adhesion Damage to endothelium exposes blood to the subepithelial tissue matrix (collagen) Injured endothelium releases a plasma cofactor protein (von Willebrand Factor) which attaches to the platelet membrane glycoprotein receptor causing adhesion. (Congenital absence of vwf causes bleeding disorder)

2. Formation of Platelet plug Contact with damaged endothelium/collagen changes in platelets shape. Swelling, more irregular shape with multiple pseudopodia, forceful contraction (due to calcium mediated contraction of actin and myosin) and degranulation with release of multiple active factors Become sticky and adhere to collagen via von Willebrand factor Secrete large quantities of ADP and form thromboxane A2 from arachidonic acid. The release of large amounts of ADP combined with thromboxane A2 amplifies the initial aggregation of platelets (positive feedback ) into a large platelet mass formation of the platelet plug.

FORMATION OF PLATELETS PLUG

The third mechanism of hemostasis Mechanism of Blood Clotting

Balance between anticoagulants and procoagulants Normally blood in blood vessel kept in fluid state because of dominancy of anticoagulants factors. When blood vessel is traumatized, locally the procoagulants are activated and clot develops clot procoagulants Fluid state anticoagulants

Blood coagulation in ruptured BV Starts quickly -20 seconds in severe bleeding, and 1-2 minutes in minor trauma. Interaction between substances released from traumatized blood vessel wall, platelets and clotting factors.

Fate of blood clot Blood clot formed in the body follows one of these two courses: 1. invasion of the clot by fibroblasts starts few hours after clot formation. It converts clot in the wall of the blood vessel into fibrous tissue within 1-2 weeks. *** platelets enhance this process through growth factor that they secrete. 2. Dissolving of the clot.

General mechanism of blood ** Three essential steps: When blood vessel is injured a cascade of complex chemical reactions results in formation of activated substances collectively called prothrombin activator. Prothrombin activator converts prothrombin into Thrombin Thrombin converts fibrinogen into Fibrin fibers clotting

Prothrombin (clotting factor II) Plasma protein of globulin type. MW= 68000 Produced by liver. It must be produced continuously because it is continuously consumed by the body. Its production needs vit. K. Plasma concentration 15 mg/dl. When activated, it produces thrombin which acts on fibrinogen. Prothrombin attaches to platelets on the site of injury.

Fibrinogen (clotting factor I) MW=340000 Plasma concentration 0.1-0.7 g/dl Formed in the liver. Thrombin acts on fibrinogen producing fibrin monomers which polymerize into long fibrin fibers. Fibrin fibers form the meshwork of the clot. The meshwork of the fibrin fibers is strengthened by fibrin stabilizing factor (XIII).

Fibrinogen (cont.) 3 stages of conversion of fibrinogen to fibrin Proteolysis Thrombin cleavage of fibrinogen results in fibrin monomers Polymerization Spontaneous self-assembly into fibrin polymers Stabilization Introduction of covalent bonds into fibrin polymers by XIIIa

Formation of prothrombin activator (Clotting Cascade**) Has two semi-independent pathways The intrinsic pathway has all of its components within the blood. It begins in the blood itself. The extrinsic pathway is triggered by extravascular tissue damage; this pathway is activated by exposure to a tissue factor (trauma to blood vessel wall and surrounding tissues) Both pathways result in activation of prothrombin (factor II) The intrinsic pathway is relatively slow (1-6 minutes) The extrinsic pathway is quite fast (15 seconds) ** In Clotting Cascade, Each coagulation factor is converted to an active form by the previous factor in the cascade

CLOTTING FACTORS

EXTRINSIC PATHWAY Tissue factor (tissue thromboplastin) : Phospholipid from damaged tissues. The extrinsic pathway is initiated when there is an injury to a blood vessel wall and release of tissue factor Note: Prothrombin activator is a complex consists of Xa, Va, Ca++ and platelet phospholipid

INTRINSIC PATHWAY Starts when blood exposes to rough surface (collagen in blood vessel wall. Exposure of blood to collagen activates factor XII and causes release of phospholipids from platelets.

Contact with collagen

Important points in Blood clotting 1. All factors or procoagulants present in blood in INACTIVE forms. 2. INJURY to tissue, blood vessel wall, cells, platelets is essential for initiation of blood clotting. 3. Ca ++ is required for all steps of intrinsic and extrinsic mechanisms EXCEPT for converting XIIa and Xla. 4. Clotting promotes more clot formation (vicious cycle - positive feed back). 5. Most of clotting factors are produced in liver. 6. Formation of clotting factors II, VII, IX and X in the liver needs presence of vitamin K.

Summary of sequence of events after vessel injury - Vasoconstriction- Controlled by vessel smooth muscle; enhanced by chemicals secreted by platelets Platelet adhesion Adhesion to exposed subendothelial connective tissue Platelet aggregation Interaction and adhesion of platelets to one another to form initial plug at injury site Fibrin-platelet plug Coagulation factors interact on platelet surface to produce fibrin; fibrin-platelet plug then forms at site of vessel injury Fibrin stabilization Fibrin clot must be stabilized by Factor-XIIIa

Why blood in the vessels does not normally clot? 1. Endothelial surface factors: a. The smoothness of intact endothelium of the blood vessels. This prevents activation of intrinsic pathway. b. a layer of glycocalyx on endothelium that repels the clotting factors. c. presence of protein called thrombomodulin which binds thrombin (removing thrombin). The complex of thrombinthrombomodulin activates protein C which inactivates the activated form of factors V and VIII. 2. The rapid rate of blood flow in the blood vessels, preventing stagnation of blood.

thrombin-thrombomodulin and protein C thrombin-thrombomodulin Tissue plasminogen activator

Why blood in the vessels does not normally clot?(cont.) 3. The presence of the natural anticoagulant substance, heparin. 4. Formation of an antithrombin (known as Antithrombin III) which removes free thrombin. The effectiveness of antithrombin III as anticoagulant is increased greatly by presence of heparin. The complex of heparin-antithrombin III can remove other activated clotting factors (XII, XI, X, IX). *** HEPARIN: Is a negatively charged conjugated polysaccharide, produced by basophil and mast cells. It is used in medical practice to prevent intravascular clotting).

PREVENTION OF BLOOD CLOTTING IN THE NORMAL VASCULAR SYSTEM Antithrombin action of Fibrin and antithrombin III. When a clot is forming 85-90% of thrombin formed from prothrombin becomes adsorbed to fibrin fibers. Antithrombin III combines with any thrombin which is not adsorbed to fibrin and blocks its effect on fibrinogen and inactivates the bound thrombin.

Lysis of blood clot Blood contains protein called plasminogen which can be activated into proteolytic enzyme called PLASMIN. Plasmin digest fibrin fibers (so causes lysis of the clot) it also digests fibrinogen, prothrombin, factors V, VIII and XII (It sometimes decreases the coagulability of the blood). Tissue plasminogen activator (t- PA) produced by injured tissues and endothelium. It coverts plasminogen which entrapped in the clot into plasmin which digest fibrin fibers.

Lysis of blood clots Plasmin (cont.) Significance of plasmin system: The lysis of blood clots allows slow clearing (over a period of several days) of extraneous clotted blood in tissues and sometimes allows reopening of clotted vessels. It helps to remove minute clots from the millions of tiny peripheral vessels. [this is the basis for using t-pa or streptokinase for treating intravascular clots in pulmonary or coronary artery]

LABORATORY EVALUATION OF HEMOSTASIS DISORDERS Platelets disorders present as petechiae and bleeding into mucous membranes because of failure to form the platelets plug. Patients with coagulation defects may develop deep spreading hematomas, bleeding into the joints and hematuria because of failure of blood clotting. Platelets functions evaluation Peripheral blood smear evaluation bleeding time (N=1-6 min) Clotting factors evaluation Clotting time (N=6-10 min) Prothrombin time (PT) measures the extrinsic and common pathways (N=11-13 sec). Activated partial thromboplastin time (APTT) measure intrinsic pathway (N=30-40 sec).